Found 10 matching trials
Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing
PHASE2Subjects will attend the unit for out-patient visits on Day 1, Day 7, Day 1...
Location
GSK Investigational Site
A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
PHASE2This study is an 8 day, randomised, double blind, 2-way crossover trial of ...
Location
GSK Investigational Site
A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
PHASE2This current study is planned as a dedicated pharmacodynamic (effect of dru...
Location
GSK Investigational Site
A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
PHASE2This is an 8 day, randomised, double blind, 3-way crossover trial of repeat...
Location
GSK Investigational Site
Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients
PHASE2This study will evaluate the safety and tolerability of the cfor the first ...
Location
GSK Investigational Site
Endotoxin Challenge Study For Healthy Men and Women
PHASE1The proposed study will examine the effect of pre-treatment with inhaled GS...
Location
GSK Investigational Site
Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
PHASE2This study is in patients with seasonal allergic rhinitis (SAR) and will co...
Location
GSK Investigational Site
This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
PHASE2This will be a single centre, randomised, double-blind, placebo-controlled,...
Location
GSK Investigational Site
Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
PHASE2This study will evaluate the efficacy and safety of GSK256066 in the treatm...
Location
GSK Investigational Site
Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
PHASE2This study is in patients with seasonal allergic rhinitis(SAR)and will comp...
Location
GSK Investigational Site